PolyPeptide Group AG announced that for 2024, the company expands a mid- to high single-digit revenue growth at constant currency rates. The company do expect to operate a net loss.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.85 CHF | +1.23% | +1.23% | +87.50% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+87.50% | 1.22B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- PPGN Stock
- News PolyPeptide Group AG
- PolyPeptide Group AG Provides Earnings Guidance for 2024